We are pleased to announce the print publication of article, “Activity of 2 Methoxyestradiol (Panzem® NCD) in Advanced, Platinum-Resistant Ovarian Cancer and Primary Peritoneal Carcinomatosis: A Hoosier Oncology Group Trial”.
Citation:
Daniela Matei, Jeanne Schilder, Gregory Sutton, Susan Perkins, Tim Breen, Check Quon, Carolyn Sidor. Activity of 2 Methoxyestradiol (Panzem® NCD) in Advanced, Platinum-Resistant Ovarian Cancer and Primary Peritoneal Carcinomatosis, a Hoosier Oncology Group Trial, Gynecologic Oncology 115 (2009) 90–96. PMID: 19577796
Thank you to Dr. Matei, her team, and to all the research sites for their participation and support of this very important clinical trial.
Download Full Manuscript in PDF